Cidara’s Novel Antifungal Approved For Antimicrobial-Resistant C. Auris Infections
Executive Summary
Cidara’s US commercial partner Melinta will launch the novel echinocandin this summer, announcing pricing shortly before rollout. Limited indication follows recommendation of FDA advisory panel.